- Home
- USEG vs GNTA Comparison
USEG vs GNTA Comparison
Compare USEG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USEG | GNTA |
|---|---|---|
| Founded | 1966 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 34.0M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | USEG | GNTA |
|---|---|---|
| Price | $1.15 | $0.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 110.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,379,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $57.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $0.71 |
| 52 Week High | $2.75 | $10.00 |
Technical Indicators
Market Signals| Indicator | USEG | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 54.26 | 41.21 |
| Support Level | $1.12 | $0.71 |
| Resistance Level | $1.29 | $1.70 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 34.21 | 38.40 |
Price Performance
Historical ComparisonAbout USEG U.S. Energy Corp. (DE)
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.